A transcriptional regulatory network of HNF4α and HNF1α involved in human diseases and drug metabolism.

IF 3.8 2区 医学 Q2 PHARMACOLOGY & PHARMACY Drug Metabolism Reviews Pub Date : 2022-11-01 DOI:10.1080/03602532.2022.2103146
Jianxin Yang, Xue Bai, Guiqin Liu, Xiangyang Li
{"title":"A transcriptional regulatory network of HNF4α and HNF1α involved in human diseases and drug metabolism.","authors":"Jianxin Yang,&nbsp;Xue Bai,&nbsp;Guiqin Liu,&nbsp;Xiangyang Li","doi":"10.1080/03602532.2022.2103146","DOIUrl":null,"url":null,"abstract":"<p><p>HNF4α and HNF1α are core transcription factors involved in the development and progression of a variety of human diseases and drug metabolism. They play critical roles in maintaining the normal growth and function of multiple organs, mainly the liver, and in the metabolism of endogenous and exogenous substances. The twelve isoforms of HNF4α may exhibit different physiological functions, and HNF4α and HNF1α show varying or even opposing effects in different types of diseases, particularly cancer. Additionally, the regulation of CYP450, phase II drug-metabolizing enzymes, and drug transporters is affected by several factors. This article aims to review the role of HNF4α and HNF1α in human diseases and drug metabolism, including their structures and physiological functions, affected diseases, regulated drug metabolism genes, influencing factors, and related mechanisms. We also propose a transcriptional regulatory network of HNF4α and HNF1α that regulates the expression of target genes related to disease and drug metabolism.</p>","PeriodicalId":11307,"journal":{"name":"Drug Metabolism Reviews","volume":"54 4","pages":"361-385"},"PeriodicalIF":3.8000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Metabolism Reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03602532.2022.2103146","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

HNF4α and HNF1α are core transcription factors involved in the development and progression of a variety of human diseases and drug metabolism. They play critical roles in maintaining the normal growth and function of multiple organs, mainly the liver, and in the metabolism of endogenous and exogenous substances. The twelve isoforms of HNF4α may exhibit different physiological functions, and HNF4α and HNF1α show varying or even opposing effects in different types of diseases, particularly cancer. Additionally, the regulation of CYP450, phase II drug-metabolizing enzymes, and drug transporters is affected by several factors. This article aims to review the role of HNF4α and HNF1α in human diseases and drug metabolism, including their structures and physiological functions, affected diseases, regulated drug metabolism genes, influencing factors, and related mechanisms. We also propose a transcriptional regulatory network of HNF4α and HNF1α that regulates the expression of target genes related to disease and drug metabolism.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
HNF4α和HNF1α参与人类疾病和药物代谢的转录调控网络。
HNF4α和HNF1α是参与多种人类疾病发生发展和药物代谢的核心转录因子。它们在维持多器官(主要是肝脏)的正常生长和功能,以及内源性和外源性物质的代谢中发挥关键作用。HNF4α的12种亚型可能表现出不同的生理功能,并且HNF4α和HNF1α在不同类型的疾病,特别是癌症中表现出不同甚至相反的作用。此外,CYP450、II期药物代谢酶和药物转运体的调节受到多种因素的影响。本文旨在综述HNF4α和HNF1α在人类疾病和药物代谢中的作用,包括其结构和生理功能、影响疾病、调节药物代谢基因、影响因素和相关机制。我们还提出了HNF4α和HNF1α的转录调控网络,调控与疾病和药物代谢相关的靶基因的表达。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drug Metabolism Reviews
Drug Metabolism Reviews 医学-药学
CiteScore
11.10
自引率
1.70%
发文量
21
审稿时长
1 months
期刊介绍: Drug Metabolism Reviews consistently provides critically needed reviews of an impressive array of drug metabolism research-covering established, new, and potential drugs; environmentally toxic chemicals; absorption; metabolism and excretion; and enzymology of all living species. Additionally, the journal offers new hypotheses of interest to diverse groups of medical professionals including pharmacologists, toxicologists, chemists, microbiologists, pharmacokineticists, immunologists, mass spectroscopists, as well as enzymologists working in xenobiotic biotransformation.
期刊最新文献
Role of Herbal Extracts in Modulating Drug Metabolism: Implications for Pharmacokinetics, Enzyme Regulation, and Therapeutic Outcome. Pharmacokinetic considerations and strategies for antibody-based therapeutics. Phase II metabolism in xenobiotic biotransformation: general mechanisms and the underestimated role of microbial systems. An in-depth review of PPARγ modulators as anti-diabetes therapeutics. Traditional Chinese medicine and gut microbiota: biotransformation, interaction, and implications for chronic disease treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1